Results 81 to 90 of about 33,349 (194)

Vaccination Coverage for Medically Indicated Vaccines in a Convenience Sample of Severely Immunocompromised Patients with COVID-19: An Observational Cohort Study

open access: yesVaccines
Background: In recent decades, the number of immunocompromised patients (ICPs) has increased significantly. ICPs have an impaired immune system, making them susceptible to complicated infections.
Elsemieke te Linde   +4 more
doaj   +1 more source

Prevalence of human papillomavirus infection and genotype distribution among high-risk Korean women for prospecting the strategy of vaccine development

open access: yesVirology Journal, 2010
We investigated the prevalence of human papillomavirus (HPV) infection and the distribution of high-risk HPV genotypes among 2,308 high-risk Korean women to predict how much the current prophylactic HPV vaccines might affect the prevention of cervical ...
Rhee Jee Eun   +9 more
doaj   +1 more source

Risk stratification and anal cancer screening in immunocompetent women with genital HPV: Value of multicentric HSIL and performance of HPV‐based screening

open access: yesInternational Journal of Cancer, Volume 159, Issue 4, Page 1017-1027, 15 August 2026.
What's new? Anal squamous cell carcinoma (ASCC) incidence is increasing, with most cases occurring in immunocompetent women. ASCC risk is linked in particular to genital human papillomavirus (HPV) infection and HPV‐associated high‐grade squamous intraepithelial lesions (HSILs).
Isabel Matas   +13 more
wiley   +1 more source

Deep Mutational Scanning for the Study and Engineering of Protein Assemblies

open access: yesChemistry–Methods, Volume 6, Issue 8, August 2026.
This review explores how deep mutational scanning (DMS) can be used to improve understanding and accelerate engineering of protein assemblies, from natural fibers to engineered nanocages. We discuss various types of protein assemblies and their characterization, provide an introduction to the DMS technique, and then highlight examples in which DMS has ...
Jenna B. Wolfanger   +2 more
wiley   +1 more source

Tumor‐infiltrating lymphocyte (TIL) therapy: Historical context, clinical applications, and future directions

open access: yesCancer, Volume 132, Issue 15, 1 August 2026.
Abstract In the past 15 years, immunotherapy has become a major strategy for cancer therapy. Tumor‐infiltrating lymphocyte (TIL) therapy has been under investigation for nearly four decades and received its first Food and Drug Administration approval in 2024, when lifileucel was approved for patients with previously treated metastatic melanoma.
Shen Li   +5 more
wiley   +1 more source

Implementation and impact of primary HPV testing in cervical cancer screening: Historical perspectives and institutional experience at a large academic medical center

open access: yesCancer Cytopathology, Volume 134, Issue 8, August 2026.
Abstract Recognition of high‐risk human papillomavirus (HPV) as the etiologic agent in nearly all cervical cancers has fundamentally reshaped screening strategies, driving the development and adoption of highly sensitive molecular HPV assays. Over the past several decades, cervical cancer screening guidelines have shifted from primarily cytology‐based ...
Rebecca A. Yoda, Eric C. Huang
wiley   +1 more source

Factors Associated With Cervical Cancer Awareness Among Women of Reproductive Age in the Democratic Republic of the Congo: Evidence From a Nationwide DHS Analysis

open access: yesCancer Reports, Volume 9, Issue 8, August 2026.
ABSTRACT Background Cervical cancer (CC) is a major public health concern, ranked as the fourth leading cause of cancer. Evidence shows that CC is preventable if detected and treated at the early stages. In the Democratic Republic of the Congo (DRC), national‐level evidence on women’s awareness of CC and its associated factors remains limited.
Jovinary Adam   +6 more
wiley   +1 more source

Efficacy of Human Papillomavirus Vaccines for Recalcitrant Anogenital and Oral Warts. [PDF]

open access: yesJ Clin Med, 2023
Ciccarese G   +5 more
europepmc   +1 more source

Awareness of Human Papillomavirus (HPV), Increasing Rates of Oropharyngeal Cancer, and Estimated Economic Burden in Denmark

open access: yesInternational Journal of Cancer, Volume 159, Issue 3, Page 566-571, 1 August 2026.
Human papillomavirus (HPV) is a highly prevalent sexually transmitted infection. This comprehensive assessment of HPV public awareness in Denmark shows that despite the high national HPV vaccination coverage and growing public health focus on HPV‐related diseases, more than one‐third of survey respondents had never heard of HPV and fewer than 40 ...
Kathrine Kronberg Jakobsen   +6 more
wiley   +1 more source

Parents' Acceptance of COVID-19 Compared to Human Papillomavirus Vaccines. [PDF]

open access: yesJ Adolesc Health, 2022
Footman A   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy